MR

Madhu Ramesh Sahni

Director DIN 05295893
DIN 05295893 First appointment Jul 2012
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Jul 2012
Shareholding value β€’β€’β€’β€’ Premium profile

About Madhu Ramesh Sahni

Data last updated:

Madhu Ramesh Sahni was a Director at Yoshimura Pharma Private Limited (from 2013) and Director at Risingsun Chemical & Compounds Private Limited (from 2012).

DIN 05295893
First Appointment 27 Jul 2012
Oldest Company Age 14 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Yoshimura Pharma Private Limited U24233TG2013PTC090877
Director06 Nov 20132013Strike Off
Director27 Jul 20122012Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Yoshimura Pharma Private Limited
Risingsun Chemical & Compounds Private Limited
Premium access

Shareholding and investment profile for Madhu Ramesh Sahni

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Madhu Ramesh Sahni

Madhu Ramesh Sahni was first appointed on 27 Jul 2012 as Director at Risingsun Chemical & Compounds Private Limited. The most recent appointment on record is 06 Nov 2013 at Yoshimura Pharma Private Limited.

Madhu Ramesh Sahni held 2 earlier board appointments: Yoshimura Pharma Private Limited (Director, from 06 Nov 2013); Risingsun Chemical & Compounds Private Limited (Director, from 27 Jul 2012).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available